As of May 22
| +0.23 / +0.25%|
The 7 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 100.00, with a high estimate of 125.00 and a low estimate of 85.00. The median estimate represents a +10.18% increase from the last price of 90.76.
The current consensus among 7 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.